Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV.
about
Chagas disease and transfusion medicine: a perspective from non-endemic countriesTransfusion-transmitted infectionsTransfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study.Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients.Transfusion-transmitted parasitic infections.Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step.Photoinactivation of Trypanosoma cruzi in red cell suspensions with thiopyrylium.Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.Photochemical inactivation of chikungunya virus in human apheresis platelet components by amotosalen and UVA light.Emerging Pathogens - How Safe is Blood?A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States.In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function.Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates.Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates.Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiation.In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates.Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma.The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets.Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods.
P2860
Q26777968-2D4F992F-0DAB-4B32-A017-1395610CF383Q27480405-804B46E4-5A8F-4F71-ABA5-5F0BF315B709Q33370536-C3F3FC4E-5187-4D30-8A74-922F96012AC7Q33394967-1EC45802-A58A-48D2-AA42-7F19B06C2E0FQ34118802-973E7F85-7F60-4CB7-A823-2DFAE596C678Q35095646-7081D10F-E9D5-45AF-96BF-AF5061A1A1DDQ35265232-DBFFE140-2232-461D-86DF-43D6E77489FBQ36148793-555D1A8E-522E-43FF-9753-616F10AADD32Q37045828-68D9FD03-5173-4305-BB7C-811E5C1C3CD5Q37119569-AB39E64C-C3F0-466C-A934-73A1F6ED0D60Q37630317-4AA69DBE-DDF9-4DD9-BDAF-FB89AF215BC2Q38052141-1C7188F8-B2A2-4FF7-8991-B9248A44599EQ40409628-9865DB03-2AD7-49C1-821B-3E9936A5E067Q41453112-F74A6F0D-32C2-453D-BE3F-7421B3B818FBQ41461282-7614D3D2-A2D3-41C7-8265-0309DE2717B9Q45303414-E9ADCA13-53A1-40B8-B0E9-344ED65B9FCBQ46500516-7250D0A4-4D31-4DB6-BFBE-4BB958A7741AQ46651577-F5711615-987B-4A48-B088-9E5E0D749474Q46677422-D5F0A021-011D-41BE-8836-A011696B5C36Q46743693-C18E4D4B-4539-4B59-A76E-72572A34510DQ46978173-0C8DD49D-FDA3-4468-95F6-33C9C590FE27Q50474223-A6AB5D4B-7AEA-4A0C-8750-683E0EC024BAQ50704130-F5BD273E-7FE5-43A4-A087-89028EF42BBCQ51234986-2AA03475-34FE-448B-A6ED-1D7760EAF547Q53563730-4A6AEB41-C1A8-438C-B6E5-9B97AB1AD2A0Q54439376-DB70E1DC-6465-43F1-A14C-F759B3B1B7DF
P2860
Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Trypanosoma cruzi inactivation ...... n HCl) and long-wavelength UV.
@en
Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen
@nl
type
label
Trypanosoma cruzi inactivation ...... n HCl) and long-wavelength UV.
@en
Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen
@nl
prefLabel
Trypanosoma cruzi inactivation ...... n HCl) and long-wavelength UV.
@en
Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen
@nl
P2093
P2860
P1476
Trypanosoma cruzi inactivation ...... n HCl) and long-wavelength UV.
@en
P2093
Kent Dupuis
Lynn K Barrett
Richard T Eastman
Ryan Alfonso
Wesley C Van Voorhis
P2860
P304
P356
10.1128/AAC.47.2.475-479.2003
P407
P577
2003-02-01T00:00:00Z